Peptide Therapeutics Market (2021 Edition) - Analysis By Drug Type (Generic, Innovative), Manufacturing Type (In-House, Outsourced), Application,, By Region, By Country: Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)

Report
220 Pages
September 2021
Region: Global
Azoth Analytics
ID: 5448575

The Global Peptide Therapeutics Market is valued at USD 32.1 Billion in the year 2020. The growth of Peptide Therapeutics is directly associated with drug development. New drug discovery and product launch in chronic metabolic disorders would provide fruitful opportunities for Peptide Therapeutics Market. The factors such as surging prevalence of cancer, rising healthcare expenditure, growing incidence of metabolic disorders, increasing geriatric population and accelerating number of approved peptide-based therapeutic drugs.

New drug discovery and product launch in chronic metabolic disorders expected to provide potential opportunities to Peptide Therapeutics Market, further supported by factors such as surging prevalence of cancer, rising healthcare expenditure, growing incidence of metabolic disorders, increasing geriatric population and accelerating number of approved peptide-based therapeutic drugs. Over the years, the rising popularity of biologics, such as peptide therapeutics, have led to an evident shift in the focus of the healthcare industry, from traditional small molecule-based interventions to upcoming, albeit complex, family of pharmacological interventions.

The success of peptide therapeutics, so far, can be attributed to their clinical benefits, which include high target specificity, low toxicity and favorable safety profiles. Furthermore, with enhanced technologies, the prospects of the peptide drugs are getting influential day by day and new peptides are being discovered to be developed as peptide drug. Peptide therapeutics is completely different from the traditional way and may open a new window for finding completely new peptide drugs. Moreover, Peptide gives an opportunity for therapeutics intervention that follows natural pathways hence there has been decline in non-peptide chemically synthesized drug discovery as well as rise in peptide generic market and collaboration of pharmaceutical companies with biotechnology fueling the market growth of peptide therapeutics.

Scope of the Report

The report presents the analysis of Peptides Therapeutic market for the historical period 2016-2020 and forecast period of 2021-2026.
The report analyses the Peptides Therapeutic Market by value (USD Million).
The report analyses the Peptides Therapeutic Market by Application (Metabolic, Oncology, Gastrointestinal, Cardiovascular, Neurological, Others).
The report analyses the Peptides Therapeutic Market Drug Type (Generic, innovative).
The report analyses the Peptides Therapeutic Market Manufacturing Type (In-house, Outsourced).
The Global Peptides Therapeutic Market has been analysed By Region (North America, Europe, Asia Pacific and LAMEA) By Country (United States, Canada, Germany, U.K, France, Italy, China, Japan, India and South Korea).
The key insights of the report have been presented through the frameworks of the attractiveness of the market has been presented by region, by Application, By drug type and By Manufacturing type.
Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Novartis, Sanofi, Pfizer, GlaxoSmithKline, Eli Lily and Company, AstraZeneca Plc., Novo Nordisk, Amgen Inc., Takeda Pharmaceutical Company Limited, Bristol-Mayer Squibb

Key Target Audience:

Biotechnology Companies
Healthcare & Pharmaceutical Companies
Consulting and Advisory Firms
Government and Policy Makers
Regulatory Authorities

1. Report Scope and Methodology

1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary

2.Strategic Recommendations

2.1 Increase bioavailability of drugs and broaden application of peptides therapeutic
2.2 Asia Pacific region to witness augmented growth in the forecast period

3.Peptides Therapeutic Market: Product Outlook

4.Global Peptides Therapeutic Market: Sizing and Forecast

4.1 Global Peptides Therapeutic Market Size, By Value, Year 2016-2026

5.Global Peptides Therapeutic Market Segmentation - By Application, By Drug Type, By Manufacturing Type

5.1Competitive Scenario of Global Peptides Therapeutic Market: By Application
5.1.1 Metabolic - Market Size and Forecast (2016-2026)
5.1.2 Oncology - Market Size and Forecast (2016-2026)
5.1.3 Gastrointestinal - Market Size and Forecast (2016-2026)
5.1.4 Cardiovascular - Market Size and Forecast (2016-2026)
5.1.5 Neurological - Market Size and Forecast (2016-2026)
5.1.6 Others - Market Size and Forecast (2016-2026)
5.2 Competitive Scenario of Global Peptides Therapeutic Market: By Drug Type
5.2.1 Generic - Market Size and Forecast (2016-2026)
5.2.2 Innovative- Market Size and Forecast (2016-2026)
5.3 Competitive Scenario of Global Peptides Therapeutic Market: By Manufacturing Type
5.3.1 In-house - Market Size and Forecast (2016-2026)
5.3.2 Outsourced - Market Size and Forecast (2016-2026)

6.Global Peptides Therapeutic Market: Regional Analysis

6.1 Competitive Scenario of Global Peptides Therapeutic Market: By Region

7.North America Peptides Therapeutic Market: An Analysis (2016-2026)

7.1 North America Peptides Therapeutic Market: Size and Forecast (2016-2026), By Value
7.2 North America Peptides Therapeutic Market - Prominent Companies
7.3 Market Segmentation By Application (Metabolic, Oncology, Gastrointestinal, Cardiovascular, Neurological and Others)
7.4 Market Segmentation By Drug Type (Generic, Innovative)
7.5 Market Segmentation By Manufacturing Type (In-house, Outsourced)
7.6 North America Peptides Therapeutic Market: Country Analysis
7.7 Market Opportunity Chart of North America Peptides Therapeutic Market - By Country, By Value, 2026
7.8 Competitive Scenario of North America Peptides Therapeutic Market: By Country
7.9 United States Peptides Therapeutic Market: Size and Forecast (2016-2026), By Value
7.10 United States Peptides Therapeutic Market Segmentation - By Application, By Drug Type, By Manufacturing Type (2016-2026)
7.11 Canada Peptides Therapeutic Market: Size and Forecast (2016-2026), By Value
7.12 Canada Peptides Therapeutic Market Segmentation - By Application, By Drug Type, By Manufacturing Type (2016-2026)

8. Europe Peptides Therapeutic Market: An Analysis (2016-2026)

8.1 Europe Peptides Therapeutic Market: Size and Forecast (2016-2026), By Value
8.2 Europe Peptides Therapeutic Market - Prominent Companies
8.3 Market Segmentation By Application (Metabolic, Oncology, Gastrointestinal, Cardiovascular, Neurological and Others)
8.4 Market Segmentation By Drug Type (Generic, Innovative)
8.5 Market Segmentation By Manufacturing Type (In-house, Outsourced)
8.6 Europe Peptides Therapeutic Market: Country Analysis
8.7 Market Opportunity Chart of Europe Peptides Therapeutic Market - By Country, By Value, 2026
8.8 Competitive Scenario of Europe Peptides Therapeutic Market: By Country
8.9 Germany Peptides Therapeutic Market: Size and Forecast (2016-2026), By Value
8.10 Germany Peptides Therapeutic Market Segmentation - By Application, By Drug Type, By Manufacturing Type (2016-2026)
8.11 United Kingdom Peptides Therapeutic Market: Size and Forecast (2016-2026), By Value
8.12 United Kingdom Peptides Therapeutic Market Segmentation - By Application, By Drug Type, By Manufacturing Type (2016-2026)
8.13 France Peptides Therapeutic Market: Size and Forecast (2016-2026), By Value
8.14 France Peptides Therapeutic Market Segmentation - By Application, By Drug Type, By Manufacturing Type (2016-2026)
8.15 Italy Peptides Therapeutic Market: Size and Forecast (2016-2026), By Value
8.16 Italy Peptides Therapeutic Market Segmentation - By Application, By Drug Type, By Manufacturing Type (2016-2026)

9. Asia Pacific Peptides Therapeutic Market: An Analysis (2016-2026)

9.1 Asia Pacific Peptides Therapeutic Market: Size and Forecast (2016-2026), By Value
9.2 Asia Pacific Peptides Therapeutic Market - Prominent Companies
9.3 Market Segmentation By Application (Metabolic, Oncology, Gastrointestinal, Cardiovascular, Neurological and Others)
9.4 Market Segmentation By Drug Type (Generic, Innovative)
9.5 Market Segmentation By Manufacturing Type (In-house, Outsourced)
9.6 Asia Pacific Peptides Therapeutic Market: Country Analysis
9.7 Market Opportunity Chart of Asia Pacific Peptides Therapeutic Market - By Country, By Value, 2026
9.8 Competitive Scenario of Asia Pacific Peptides Therapeutic Market: By Country
9.9 China Peptides Therapeutic Market: Size and Forecast (2016-2026), By Value
9.10 China Peptides Therapeutic Market Segmentation - By Application, By Drug Type, By Manufacturing Type (2016-2026)
9.11 Japan Peptides Therapeutic Market: Size and Forecast (2016-2026), By Value
9.12 Japan Peptides Therapeutic Market Segmentation - By Application, By Drug Type, By Manufacturing Type (2016-2026)
9.13 India Peptides Therapeutic Market: Size and Forecast (2016-2026), By Value
9.14 India Peptides Therapeutic Market Segmentation - By Application, By Drug Type, By Manufacturing Type (2016-2026)
9.15 South Korea Peptides Therapeutic Market: Size and Forecast (2016-2026), By Value
9.16 South Korea Peptides Therapeutic Market Segmentation - By Application, By Drug Type, By Manufacturing Type (2016-2026)

10.Global Peptides Therapeutic Market Dynamics

10.1 Drivers
10.2 Restraints
10.3 Trends

11.Market Attractiveness

11.1 Market Attractiveness Chart of Global Peptides Therapeutic Market - By Application, 2026
11.2 Market Attractiveness Chart of Global Peptides Therapeutic Market - By drug Type, 2026
11.3 Market Attractiveness Chart of Global Peptides Therapeutic Market - By Manufacturing Type, 2026
11.4 Market Attractiveness Chart of Global Peptides Therapeutic Market - By Region, 2026

12.Competitive Landscape

12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 Market Share Analysis

13.Company Analysis

13.1 Novartis
13.2 Sanofi
13.3 Pfizer
13.4 GlaxoSmithkline
13.5 Eli Lily and Company
13.6 AstraZeneca Plc
13.7 Novo Nordisk
13.8 Amgen Inc
13.9 Takeda Pharmaceutical Company Limited
13.10 Bristol-Mayer Squibb

List of Figures

Global Peptides Therapeutic Market Size, By Value, 2016-2026 (USD Million)
Global Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Global Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Global Prevalence of Neurological Disorders, 2015-2019 (In Billions)
Global Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Global Prevalence of Total Cancer, 2015-2019 (In Millions)
Global Peptides Therapeutic Market- By Application Market Share, 2020 & 2026
Global Peptides Therapeutic Market- By Metabolic , By Value (USD Million), 2016-2026
Global Peptides Therapeutic Market- By Oncology , By Value (USD Million), 2016-2026
Global Peptides Therapeutic Market- By Gastrointestinal, By Value (USD Million), 2016-2026
Global Peptides Therapeutic Market- By Cardiovascular , By Value (USD Million), 2016-2026
Global Peptides Therapeutic Market- By Neurological , By Value (USD Million), 2016-2026
Global Peptides Therapeutic Market- By Others, By Value (USD Million), 2016-2026
Global Peptides Therapeutic Market- By Drug Type Market Share, 2020 & 2026
Global Peptides Therapeutic Market- By Generic, By Value (USD Million), 2016-2026
Global Peptides Therapeutic Market- By Innovative, By Value (USD Million), 2016-2026
Global Peptides Therapeutic Market- By Manufacturing Type Market Share, 2020 & 2026
Global Peptides Therapeutic Market- By In-house, By Value (USD Million), 2016-2026
Global Peptides Therapeutic Market- By Outsourced, By Value (USD Million), 2016-2026
Global Peptides Therapeutic Market- By Region Market Share, 2020 & 2026
North America Peptides Therapeutic Market Size, By Value, 2016-2026 (USD Million)
North America Prevalence of Neurological Disorders, 2015-2019 (In Millions)
North America Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
North America Prevalence of Total Cancer, 2015-2019 (In Millions)
North America Peptides Therapeutic Market- By Application, By Value (USD Million), 2016-2026
North America Peptides Therapeutic Market- By Drug Type, By Value (USD Million), 2016-2026
North America Peptides Therapeutic Market- By Manufacturing Type, By Value (USD Million), 2016-2026
Market Opportunity Chart of North America Peptides Therapeutic Market- By Country, By Value (Year-2026)
North America Peptides Therapeutic Market- By Country Market Share, 2020 & 2026
United States Peptides Therapeutic Market Size, By Value, 2016-2026 (USD Million)
United State Prevalence of Neurological Disorders, 2015-2019 (In Millions)
United State Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
United State Prevalence of Total Cancer, 2015-2019 (In Millions)
United State Peptides Therapeutic Market- By Application, By Value (USD Million), 2016-2026
United State Peptides Therapeutic Market- By Drug Type, By Value (USD Million), 2016-2026
United State Peptides Therapeutic Market- By Manufacturing Type, By Value (USD Million), 2016-2026
Canada Peptides Therapeutic Market Size, By Value, 2016-2026 (USD Million)
Canada Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Canada Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Canada Prevalence of Total Cancer, 2015-2019 (In Millions)
Canada Peptides Therapeutic Market- By Application, By Value (USD Million), 2016-2026
Canada Peptides Therapeutic Market- By Drug Type, By Value (USD Million), 2016-2026
Canada Peptides Therapeutic Market- By Manufacturing Type, By Value (USD Million), 2016-2026
Europe Peptides Therapeutic Market Size, By Value, 2016-2026 (USD Million)
Europe Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Europe Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Europe Prevalence of Total Cancer, 2015-2019 (In Millions)
Europe Peptides Therapeutic Market- By Application, By Value (USD Million), 2016-2026
Europe Peptides Therapeutic Market- By Drug Type, By Value (USD Million), 2016-2026
Europe Peptides Therapeutic Market- By Manufacturing Type, By Value (USD Million), 2016-2026
Market Opportunity Chart of Europe Peptides Therapeutic Market- By Country, By Value (Year-2026)
Europe Peptides Therapeutic Market- By Country Market Share, 2020 & 2026
Germany Peptides Therapeutic Market Size, By Value, 2016-2026 (USD Million)
Germany Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Germany Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Germany Prevalence of Total Cancer, 2015-2019 (In Millions)
Germany Peptides Therapeutic Market- By Application, By Value (USD Million), 2016-2026
Germany Peptides Therapeutic Market- By Drug Type, By Value (USD Million), 2016-2026
Germany Peptides Therapeutic Market- By Manufacturing Type, By Value (USD Million), 2016-2026
United Kingdom Peptides Therapeutic Market Size, By Value, 2016-2026 (USD Million)
United Kingdom Prevalence of Neurological Disorders, 2015-2019 (In Millions)
United Kingdom Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
United Kingdom Prevalence of Total Cancer, 2015-2019 (In Millions)
United Kingdom Peptides Therapeutic Market- By Application, By Value (USD Million), 2016-2026
United Kingdom Peptides Therapeutic Market- By Drug Type, By Value (USD Millon), 2016-2026
United Kingdom Peptides Therapeutic Market- By Manufacturing Type, By Value (USD Million), 2016-2026
France Peptides Therapeutic Market Size, By Value, 2016-2026 (USD Million)
France Prevalence of Neurological Disorders, 2015-2019 (In Millions)
France Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
France Prevalence of Total Cancer, 2015-2019 (In Millions)
France Peptides Therapeutic Market- By Application, By Value (USD Million), 2016-2026
France Peptides Therapeutic Market- By Drug Type, By Value (USD Million), 2016-2026
France Peptides Therapeutic Market- By Manufacturing Type, By Value (USD Million), 2016-2026
Italy Pharmacy Retail Market Size, By Value, 2016-2026 (USD Billion)
Italy Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Italy Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Italy Prevalence of Total Cancer, 2015-2019 (In Millions)
Italy Peptides Therapeutic Market- By Application, By Value (USD Million), 2016-2026
Italy Peptides Therapeutic Market- By Drug Type, By Value (USD Million), 2016-2026
Figure 81: Italy Peptides Therapeutic Market- By Manufacturing Type, By Value (USD Million), 2016-2026
Asia Pacific Peptides Therapeutic Market Size, By Value, 2016-2026 (USD Million)
Asia Pacific Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Asia Pacific Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Asia Pacific Prevalence of Total Cancer, 2015-2019 (In Millions)
Asia Pacific Peptides Therapeutic Market- By Application, By Value (USD Million), 2016-2026
Asia Pacific Peptides Therapeutic Market- By Drug Type, By Value (USD Million), 2016-2026
Asia Pacific Peptides Therapeutic Market- By Manufacturing Type, By Value (USD Million), 2016-2026
Market Opportunity Chart of APAC Peptides Therapeutic Market- By Country, By Value (Year-2026)
APAC Peptides Therapeutic Market- By Country Market Share, 2020 & 2026
China Peptides Therapeutic Market Size, By Value, 2016-2026 (USD Million)
China Prevalence of Neurological Disorders, 2015-2019 (In Millions)
China Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
China Prevalence of Total Cancer, 2015-2019 (In Millions)
China Peptides Therapeutic Market- By Application, By Value (USD Million), 2016-2026
China Peptides Therapeutic Market- By Drug Type, By Value (USD Million), 2016-2026
China Peptides Therapeutic Market- By Manufacturing Type, By Value (USD Million), 2016-2026
Japan Peptides Therapeutic Market Size, By Value, 2016-2026 (USD Million)
Japan Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Japan Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Japan Prevalence of Total Cancer, 2015-2019 (In Millions)
Japan Peptides Therapeutic Market- By Application, By Value (USD Million), 2016-2026
Japan Peptides Therapeutic Market- By Drug Type, By Value (USD Million), 2016-2026
Japan Peptides Therapeutic Market- By Manufacturing Type, By Value (USD Million), 2016-2026
India Pharmacy Retail Market Size, By Value, 2016-2026 (USD Billion)
India Prevalence of Neurological Disorders, 2015-2019 (In Millions)
India Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
India Prevalence of Total Cancer, 2015-2019 (In Millions)
India Peptides Therapeutic Market- By Application, By Value (USD Million), 2016-2026
India Peptides Therapeutic Market- By Drug Type, By Value (USD Million), 2016-2026
India Peptides Therapeutic Market- By Manufacturing Type, By Value (USD Million), 2016-2026
South Korea Peptides Therapeutic Market Size, By Value, 2016-2026 (USD Million)
South Korea Prevalence of Neurological Disorders, 2015-2019 (In Millions)
South Korea Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
South Korea Prevalence of Total Cancer, 2015-2019 (In Millions)
South Korea Peptides Therapeutic Market- By Application, By Value (USD Million), 2016-2026
South Korea Peptides Therapeutic Market- By Drug Type, By Value (USD Million), 2016-2026
South Korea Peptides Therapeutic Market- By Manufacturing Type, By Value (USD Million), 2016-2026
Market Attractiveness Chart of Global Peptides Therapeutic Market- By Application (Year 2016-2026)
Market Attractiveness Chart of Global Peptides Therapeutic Market- By Drug Type (Year-2026)
Market Attractiveness Chart of Global Peptides Therapeutic Market- By Manufacturing Type (Year 2016-2026)
Market Attractiveness Chart of Global Peptides Therapeutic Market- By Region (Year 2016-2026)
Global Peptides Therapeutic company market share (%), 2020
Novartis Annual Sales Revenue (USD Million), 2016-2020
Novartis Annual Net Income/Loss (USD Million), 2016-2020
Novartis Sales Revenue Split, By Business Segment (USD Million), FY2020
Novartis Sales Revenue Split, By Geography Segment (%), FY2020
Sanofi Sales Revenues, 2016-2020 (USD Million)
Sanofi Gross Profit, 2016-2020 (USD Million)
Sanofi Sales Revenue Split, By Business Segment (%), FY2020
Sanofi Sales Revenue Split, By Geography Segment (%), FY2020
Pfizer Annual Sales Revenue (USD Million), 2016-2020
Pfizer Annual Net Income/Loss (USD Million), 2016-2020
Pfizer sales Revenue, By Geographical Segment (%), FY2020
GlaxoSmithKline Annual Sales Revenue (USD Million), 2016-2020
GlaxoSmithKline Net Profit (USD Million), 2016-2020
GlaxoSmithKline Sales Revenue Split, By Business Segment (%), FY2020
GlaxoSmithKline Sales Revenue Split, By Geography Segment (%), FY2020
Eli Lilly and Company Annual Sales Revenue (USD Million), 2016-2020
Eli Lilly and Company Annual Net Income (USD Million), 2016-2020
Eli Lilly and Company Sales Revenue Split, By Business Segment (USD Million), FY2020
Eli Lilly and Company Sales Revenue Split, By Geography Segment (%), FY2020
AstraZeneca Sales Revenues, 2016-2020 (USD Million)
AstraZeneca Gross Profit, 2016-2020 (USD Million)
AstraZeneca Plc Sales Revenue Split, By Business Segment (%), FY2020
AstraZeneca Plc Sales Revenue Split, By Geography Segment (%), FY2020
Novo Nordisk Sales Revenues, 2016-2020 (USD Million)
Novo Nordisk Net Profit, 2016-2020 (USD Million)
Novo Nordisk Sales Revenue Split, By Business Segment (%), FY2020
Novo Nordisk Sales Revenue Split, By Geography Segment (%), FY2020
Amgen Inc. Sales Revenues, 2016-2020 (USD Million)
Amgen Inc. Net Income, 2016-2020 (USD Million)
Amgen Inc. Sales Revenue Split, By Business Segment (%), FY2020
Amgen Inc. Sales Revenue Split, By Geography Segment (%), FY2020
Takeda Pharmaceutical Company Limited Sales Revenues, 2016-2020 (USD Million)
Takeda Pharmaceutical Company Limited Net Income, 2016-2020 (USD Million)
Takeda Pharmaceutical Company Limited Sales Revenue Split, By Business Segment (%), FY2020
Takeda Pharmaceutical Company Limited Sales Revenue Split, By Geography Segment (%), FY2020
Bristol-Myers Squibb Sales Revenues, 2016-2020 (USD Million)
Bristol-Myers Squibb Net Income, 2016-2020 (USD Million)
Bristol-Myers Squibb Sales Revenue Split, By Business Segment (%), FY2020
Bristol-Myers Squibb Sales Revenue Split, By Geography Segment (%), FY2020

Table Information

Report Attribute	Details
No. of Pages	220
Published	September 2021
Forecast Period	2021 - 2026
Estimated Market Value in 2021	35.37 Billion
Forecasted Market Value by 2026	62.68 Billion
Compound Annual Growth Rate	12.1%
Regions Covered	Global

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2371EUR$2,400USD£1,974GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€2964EUR$3,000USD£2,467GBP

Scope of the Report

Key Target Audience:

Table of Contents

Table Information

Related Topics

Related Reports

Peptide Therapeutics Market Size, Share & Trends Analysis Report by Application (Cancer, Metabolic Disorders), Type (Generic, Innovative), Type of Manufacturer, Route of Administration, Synthesis Technology, Region, and Segment Forecasts, 2024-2030

Peptide Therapeutics Market by Technology, Drug Class, Route of Administration, Application, End User, Manufacturing Type - Global Forecast 2025-2030

Peptide Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030

Oral Proteins & Peptides Market by Molecule (Semaglutide, Linaclotide, Calcitonin), Drug Class (GLP-1 Receptor Agonist, GEP, CGRP), Therapeutic Area (Diabetes, Gastroenterology, Genetic Disorder), Formulation (Tablet, Capsule) - Global Forecast to 2029

Peptide Therapeutics Global Market Report 2024